Not only that, some investigators performed gene expression analysis of T‐cell infiltration in breast cancer, and the results showed20 that miR‐34a may be associated with CD4+ T‐cell infiltration, which may provide new target ideas for immunotherapy of breast cancer. This evidence concerns the gene CD4 and breast carcinoma.